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A simple and sensitive electrochemical method for the simultaneous and quantitative
detection of ranitidine (RT) and metronidazole (MT) was developed, based on a poly
(chromotrope 2B) modified activated glassy carbon electrode (PCHAGCE). The PCHAGCE
showed excellent electrocatalytic activity toward the reduction of both RT and MT in
0.1 mol/L phosphate buffer solution (pH 6.0). The peak-to-peak separations for the simul-
taneous detection of RT and MT between the two reduction waves in cyclic voltammetry
were increased significantly from w0.1 V at activated GCE, to w0.55 V at PCHAGCE. By
differential pulse voltammetry techniques, the reduction peak currents of RT and MT were
both linear over the range of 1.0  105e4.0 104 mol/L. The detection limits (S/N ¼ 3)
were 5.4  107 mol/L and 3.3  107 mol/L for RT and MT, respectively. The modified
electrode was successfully applied to the determination of RT and MT in pharmaceutical
preparations and human serum as real samples with stable and reliable recovery data.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.Open access under CC BY-NC-ND license. 1. Introduction
Ranitidine [RT; N-(2-{[(5-dimethylamino)methyl]2-furanyl}-
methylthioethyl)-N0-methyl-2-nitro-1,10-ethenodiamine] is an
inhibitor of gastric acid secretion and is used in the treatment
of gastric and duodenal ulcers. It competitively inhibits
the action of histamine on the H2 receptors of parietal cells
[1,2]. Metronidazole [MT; 2-(2-methyl-5-nitroimidazole-1-yl)
ethanol] is a 5-nitronimidazole derivative with activity against
anaerobic protozoa and anaerobic bacteria. MT is widelymistry and Chemical Eng
ministration, Taiwan. Publidistributed and appears in most body tissues and fluids
including bile, bone, breast milk, cerebral abscesses, and
saliva, and generally achieves concentrations similar to those
in plasma with the effective concentration in human serum
ranging from 2 mg/mL to 8 mg/mL [3]. The combination of these
two drugs, have been successfully used with antibiotics for
the treatment of gastric Helicobacter pylori infections [4]. They
have low plasma protein binding (20%), and their effective
plasma concentrations are 100 mg/mL and 6 mg/mL, respec-
tively [5].ineering, Henan Institute of Science and Technology, Xinxiang,
shed by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license. 
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crucial for the bioanalysis of biological fluids and drug
formulation because of the need to selectively remove the
interferents such as proteins. There are several investigations
concerning the determination of RT and/or MT in pharma-
ceutical preparations by spectrophotometry [6], ion selective
electrodes [7], fluorimetric method [8], near-infrared reflec-
tance spectrometry [9], and chromatography [5]. However, the
lack of selectivity limits the application of these methods for
pharmacokinetic studies in pharmaceutical and biological
samples. Moreover, some of these methods are poorly sensi-
tive and require expensive apparatuses, and most of them
involve several manipulation steps before when the final
result of the analysis can be obtained. Therefore, it is impor-
tant to develop a simple instrumental method with high
sensitivity and selectivity for the detection of these drugs. In
this regard, electrochemical methods have several advan-
tages: ease of operation, high sensitivity and selectivity to the
specific analytes, fast and reagentless detection, etc. RT and
MT contain an electrochemically active reducible nitro group
that leads to the development of an electrochemical sensor for
the simultaneous detection of both. The electrochemical
detection of these two drugs at carbon fiber microdisk [10] has
been reported, although the sensitivity was low. Single-wall
carbon nanotube modified electrodes [11] were reported with
high sensitivity; however, they may suffer from mechanical
instability because the electrodes were constructed by
adsorption of carbon material on substrates [12].
In the present work, we report that poly(chromotrope 2B)
(PCH) modified activated glassy carbon electrode (GCE)
(PCHAGCE) can be successfully used for the simultaneous
determination of RT and MT in pharmaceutical preparations
and human serum.Fig. 1 e Cyclic voltammograms of ranitidine and
metronidazole (0.5 mmol/L of each) in phosphate-
buffered saline at bare GCE, activated GCE, and
poly(chromotrope 2B) modified activated GCE. GCE [
glassy carbon electrode.2. Materials and methods
2.1. Reagents
All reagents were of analytical grade and were used without
further purification. RT, MT, chromotrope 2B, Na2HPO4, and
NaH2PO4 were purchased from Sigma-Aldrich, St. Louis, MI,
USA. Phosphate-buffered saline (PBS; 0.1 M) was prepared
by mixing 0.1 mol/L Na2HPO4 and NaH2PO4. All solutions
were prepared with deionized water (DI, 18MU/cm) obtained
from a XF-D water purifying system, Xuefeng Water Treat-
ment Equipment Co. Ltd, Zhengzhou, (China). All experiments
were performed at room temperature.
2.2. Apparatus
Electrochemical experiments were conducted on a CHI430A
electrochemical workstation (CH Instruments, USA). Electro-
chemical measurements were performed in a three-electrode
cell system with a GCE (3 mm diameter) or PCHAGCE, a plat-
inumwire, and a Ag/AgCl (3 mol/L KCl) electrode were used as
working, counter, and reference electrodes, respectively. All
potentials in this study referred to this reference electrode.
Differential pulse voltammograms were obtained by scanning
the potential at different potential window with the followingpulse amplitude: 100 mV/s, pulse width; 2 milliseconds, and
pulse period; 1000 milliseconds. All electrochemical experi-
ments were performed in 0.1 M PBS, unless otherwise
specified.2.3. Preparation of modified electrode
GCE was first subjected to electrochemical activation in PBS
(pH 7.0) by applying a constant potential of þ1.8 V for 5 mi-
nutes. Prior to activation, GCE was polished with 0.05 mm
alumina/water slurry on a polishing cloth (Buekler, Germany)
to a mirror-like finish, followed by sonication, and then rinsed
with water. The activated GCEs were then subjected to elec-
tropolymerization of chromotrope 2B by cyclic sweeping of
potential for 20 times from 0.4 V to 0.6 V at 100 mV/s in
0.1 mol/L PBS (pH 7.0) containing 0.5 mmol/L of chromotrope
2B, and the resulting PCHAGCE was rinsed with and stored in
PBS prior to use.3. Results and discussion
3.1. Electrochemical behavior of RT and MT at PCHAGCE
Fig. 1 shows the cyclic voltammogram (CVs) responses of a
mixture of RT and MT (0.5 mmol/L of each) at bare GCE, AGCE,
and PCHAGCE in PBS (pH 6.0). The CV obtained at bare GCE
poses a rather broad oxidation peak and the indistinguishable
peak potentials of these compounds.However, itwas observed
that RT is electrochemically active at AGCE giving a reduction
peak at ca. 0.8 V, whereas the PCHAGCE gives a significantly
distinguishable and increased reduction current with the
negative shifting of reduction peak at ca. 1.15 V. MT gives a
significantly distinguishable reduction peak and increased
peak current at PCHAGCE compared to the AGCE with the
Fig. 2 e Effect of pH on (A) peak currents and (B) peak potentials of RT and MT (0.5 mmol/L of each). MT [ metronidazole;
RT [ ranitidine.
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reduction peak current of RT and MT at PCHAGCE could be
attributed to the strong catalytic ability of PCH. In conclusion,
RT and MT give two clearly distinguishable reduction peaks at
PCHAGCEwitha significant increase in reductionpeakcurrent,
whereas the reduction of these two compounds at AGCE does
not give well-separated peak or increased peak current. It
suggested a possible use of the modified electrode for the
simultaneous determination of RT and MT.
3.2. Effect of pH
The effect of pH on the electrochemical response of RT andMT
at PCHAGCEwas evaluated by CV (as shown in Fig. 2) in the pH
range 4.0e9.0. It was observed that with the increase of the pH
of the cosolution, both reduction peaks for the two com-
pounds were sifted negatively, whereas the reduction peak
current is highest at pH 6.0 for both RT and MT. Therefore,
pH 6.0 PBS was used as the supporting electrolyte in the
following measurements.
3.3. Effect of scan rate
Fig. 3 shows the typical CVs of the electroreduction of RT(a)
andMT(b) at different scan rates. The reduction peak potential
for both RT and MT were observed to shift negatively with theFig. 3 e Cyclic voltammograms of (A) RT and (B) MT (0.5 mmol/L
carbon electrode in pH 6.0 phosphate-buffered saline at differen
80 mV/s, 100 mV/s, and 120 mV/s). Inset of each plots show the p
for RT and MT. MT [ metronidazole; RT [ ranitidine.increase in scan rate. The Ipc for both RT and MT were directly
proportional to the square root of the scan rate over the range
of 10e120 mV/s with the regression coefficient of 0.99 for both
RT and MT. This strongly suggested that the reduction of RT
and MT are diffusion controlled [13].
3.4. Simultaneous determination of RT and MT using
differential pulse voltammetry
The result described in the previous section clearly indicated
that both RT and MT can be detected independently and
simultaneously on the PCHAGCE using CV.We further studied
the quantitative detection of these compounds by differential
pulse voltammetry (DPV) techniques. Fig. 4 shows the DPVs
recorded for various concentrations (in the range of
1.0  105e4.0  104 mol/L) of RT and MT, respectively, in the
presence of a constant concentration of counterpart
(2.0  104 mol/L MT and 1.5  104 mol/L RT). The cathodic
current of RT, which peaked at ca. 1.10 V, increased linearly
as the concentration of RT increased, whereas the peak
current of MT, at w0.55 V, remained almost unchanged.
Similar patterns were observed for MT with the cathodic peak
at w0.55 V with respect to RT without any mutual interfer-
ence. The insets of both panels show the calibration plots
constructed from the DPV responses for RT and MT. This
yielded a regression equation of:of each) at poly(chromotrope 2B) modified activated glassy
t scan rates (aeg: 10 mV/s, 20 mV/s, 40 mV/s, 60 mV/s,
lot of peak current density versus square root of scan rates
Fig. 4 e Differential pulse voltammograms for poly(chromotrope 2B) modified activated glassy carbon electrode in
co-solution of (A) different concentrations (aeg: 1.03 10L5 mol/L, 5.03 10L5 mol/L, 1.03 10L4 mol/L, 1.53 10L4 mol/L,
2.03 10L4 mol/L, 3.03 10L4 mol/L, and 4.03 10L4 mol/L) of RT containing 1.53 10L4 mol/L MT and (B) different
concentrations (aeg: 1.03 10L5 mol/L, 5.03 10L5 mol/L, 1.03 10L4 mol/L, 1.53 10L4 mol/L, 2.03 10L4 mol/L, 3.03 10L4 mol/
L, and 4.03 10L4 mol/L) of MT containing 2.03 10L4 mol/L RT. Insets show the calibration plots of RT and MT.
MT [ metronidazole; RT [ ranitidine.
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pharmaceutical preparations (n[ 3).
Analyte
sample
Nominal
(mg/100 mL)
Added
(mg/100 mL)
Founda
(mg/100 mL)
Recovery
(%)
RT 150 10 159.7 97.0
20 171.0 105.0
30 179.6 98.7
MT 150 10 160.3 103.0
20 169.8 99.0
30 180.5 101.7
a Average of six measurements.and
IðmAÞ ¼ 1:602 105½MTðmol=LÞ þ 4:31
with the regression coefficient of 0.99 for both RT andMT. The
detection limits (S/N ¼ 3) of 5.4  107 mol/L and
3.3 107 mol/L were obtained for RT and MT, respectively.
3.5. Reproducibility and stability
For evaluating the reproducibility of the response, the elec-
trochemical determinations were performed 10 times
repeatedly with an identical electrode in the solution con-
taining RT and MT (0.5 mmol/L of each) at pH 6.0. The relative
standard deviations were 2.54% and 2.26% for the 10-time
measurements of RT and MT, respectively, showing a satis-
factory reproducibility of the present protocol. The storage
stability of the modified electrode was also evaluated by
measuring DPV responses after storing themodified electrode
for 2 weeks. The peak currents for RT and MT slightly
decreased ca. 3% of the original response, showing an
acceptable stability of the modified electrode.
3.6. Interference studies
In order to assess the possible use of the electrodes for the
analysis of real samples, the interference of contaminants on
the response signals was studied. The effect of possible
interfering compounds on the CV response was verified using
0.5 mmol/L of RT and MT solutions containing excess
amounts of interfering compounds. It was found that inter-
ference from metal ions and organic compounds was rather
low. Interfering current originating from Naþ, Kþ, dextrin
(500higher concentration than RT and MT), Ca2þ, Mg2þ,
Cu2þ, Fe3þ, Zn2þ (200), sucrose, glycerol, lactose, gelatin
(50), and uric acid, ascorbic acid (equal amount) was less
than 5% of the oxidation current for 0.5 mmol/L of RT and MT.
Thus, PCHAGCE was found to be rather insensitive to foreignsubstances, suggesting the usefulness of the electrode in the
analysis of real samples.
3.7. Application to real sample analysis
To investigate the applicability of the proposedmethod for the
simultaneous determination of RT and MT, pharmaceutical
preparations (RT: Jiangxi Huiren, 150 mg/tablet; MT: Shanghai
Hengshan, 150 mg/tablet) were used for quantitative analysis.
The spike and recovery experiments were performed by
measuring DPV responses for 100mLdissolved tablet solutions
in which known amounts of RT and MT were added. Their
amounts were then determined by calibration and are sum-
marized in Table 1. The recoveries for RT and MT were
97.0e105.0% and 99.0e103.0%, respectively. In addition, we
measured these analytes in the human serum sample (male
AB, from Xinxiang First People’s Hospital), Xinxiang, China
which was diluted five times with the buffer solution prior to
the measurements to prevent the matrix effect and then
spiked with a certain amount of RT andMT. The slopes of peak
current versus concentration were virtually close to those ob-
tained in Fig. 4, and the recovery rateswere 99.9% and 99.3% for
RT and MT, respectively, in three independent measurements
(100 mM of each). The above results indicate the applicability
and reliability of the proposedmethod in real sample analysis.
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In conclusion, sensitive and simple electrochemical method
for the simultaneous and quantitative detection of RT and MT
was developed based on a PCHAGCE. The PCHAGCE showed
two well-defined reduction waves for RT and MT in both CV
and DPV with a peak potential separation of ca. 0.55 V, which
was large enough for simultaneous detection. Excellent cata-
lytic activity rates for the electrochemical reduction of RT and
MT were achieved at the PCHAGCE. A linear range of
1.0 105e4.0 104 mol/L for both RT andMTwith detection
limits of 5.4  107 mol/L and 3.3  107 mol/L for RT and MT,
respectively, were obtained. The present protocol offers the
advantages of accuracy, sensitivity, and time saving as well as
simplicity of reagents and apparatus. In addition, the results
obtained in the analysis of RT and MT in pharmaceutical
preparations and human serum demonstrate the applicability
of this method for real sample analysis.Conflicts of interest
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